Satellos Bioscience Inc. (MSCL.TO)

CAD 0.66

(4.76%)

Total Assets Summary of Satellos Bioscience Inc.

  • Satellos Bioscience Inc.'s latest annual total assets in 2023 was 44.29 Million CAD , up 614.6% from previous year.
  • Satellos Bioscience Inc.'s latest quarterly total assets in 2024 Q1 was 38.25 Million CAD , down -13.64% from previous quarter.
  • Satellos Bioscience Inc. reported annual total assets of 6.19 Million CAD in 2022, down -50.75% from previous year.
  • Satellos Bioscience Inc. reported annual total assets of 12.58 Million CAD in 2021, up 1014.37% from previous year.
  • Satellos Bioscience Inc. reported quarterly total assets of 38.25 Million CAD for 2024 Q1, down -13.64% from previous quarter.
  • Satellos Bioscience Inc. reported quarterly total assets of 44.29 Million CAD for 2023 FY, up 614.6% from previous quarter.

Annual Total Assets Chart of Satellos Bioscience Inc. (2023 - 2019)

Historical Annual Total Assets of Satellos Bioscience Inc. (2023 - 2019)

Year Total Assets Total Assets Growth
2023 44.29 Million CAD 614.6%
2022 6.19 Million CAD -50.75%
2021 12.58 Million CAD 1014.37%
2020 1.12 Million CAD 5.22%
2019 1.07 Million CAD 0.0%

Peer Total Assets Comparison of Satellos Bioscience Inc.

Name Total Assets Total Assets Difference
Appili Therapeutics Inc. 1.49 Million CAD -2872.216%
Eupraxia Pharmaceuticals Inc. 26.72 Million CAD -65.767%
Helix BioPharma Corp. 1.48 Million CAD -2875.017%
Microbix Biosystems Inc. 35.65 Million CAD -24.248%
Medicenna Therapeutics Corp. 19.13 Million CAD -131.515%
Oncolytics Biotech Inc. 38.82 Million CAD -14.111%
Sernova Corp. 22.1 Million CAD -100.382%